We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Momenta Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 211 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 211 → 0 (-211)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $5.44B → $0 (-$5.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 211

Holders
–
Holders Change
-211
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
211
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.01B
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$685M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$622M
4
HI
HBK Investments
Texas
-$257M
5
State Street
State Street
Massachusetts
-$238M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
76
Polar Asset Management Partners
Ontario, Canada
– -$7.48M -142,500 Closed
WCM Investment Management
77
WCM Investment Management
California
– -$7.45M -141,884 Closed
AIMCA
78
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$7.04M -134,200 Closed
Jane Street
79
Jane Street
New York
– -$7.02M -133,819 Closed
Prudential Financial
80
Prudential Financial
New Jersey
– -$7.02M -133,729 Closed
UBS AM
81
UBS AM
Illinois
– -$6.83M -130,191 Closed
Comerica Bank
82
Comerica Bank
Texas
– -$6.52M -124,262 Closed
TS
83
Twin Securities
New York
– -$6.43M -122,500 Closed
WMSA
84
Weiss Multi-Strategy Advisers
New York
– -$6.4M -121,926 Closed
Wells Fargo
85
Wells Fargo
California
– -$6.11M -116,487 Closed
SOADOR
86
State of Alaska Department of Revenue
Alaska
– -$5.83M -111,058 Closed
HA
87
Havens Advisors
New York
– -$5.62M -107,000 Closed
New York State Common Retirement Fund
88
New York State Common Retirement Fund
New York
– -$5.6M -106,700 Closed
PMAM
89
Picton Mahoney Asset Management
Ontario, Canada
– -$5.59M -106,500 Closed
Thrivent Financial for Lutherans
90
Thrivent Financial for Lutherans
Minnesota
– -$5.18M -98,644 Closed
EP
91
Eversept Partners
New York
– -$5.17M -98,501 Closed
WAM
92
Wolverine Asset Management
Illinois
– -$5.03M -95,857 Closed
CL
93
CSS LLC
Illinois
– -$4.96M -94,521 Closed
MOACM
94
Mutual of America Capital Management
New York
– -$4.53M -86,224 Closed
PP
95
Paloma Partners
Connecticut
– -$4.34M -82,654 Closed
AIG
96
American International Group
New York
– -$4.28M -81,481 Closed
Skandinaviska Enskilda Banken (SEB)
97
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$4.04M -76,923 Closed
State of New Jersey Common Pension Fund D
98
State of New Jersey Common Pension Fund D
New Jersey
– -$4M -76,243 Closed
Two Sigma Investments
99
Two Sigma Investments
New York
– -$3.97M -75,598 Closed
CM
100
Caption Management
Oklahoma
– -$3.94M -75,000 Closed
2 3
4
5 6

MNTA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2020, worth a combined $0 — down 100% from $5.44B a quarter earlier.

Sellers outnumbered buyers: 211 funds closed out of MNTA and 0 opened new positions — a net loss of 211 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $1.01B sold.

  • 0 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2020, down from 211 in Q3 2020.
  • Funds reported $0 of Momenta Pharmaceuticals, Inc. stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2020 and 211 closed out, a net change of -211 holders.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2020 was BlackRock, an estimated $1.01B sold.

Based on aggregated 13F filings for Q4 2020.